Adamas Pharmaceuticals To Present At JMP Securities Healthcare Conference 2014 - WDAM - TV 7 - News, Weather and Sports

Adamas Pharmaceuticals To Present At JMP Securities Healthcare Conference 2014

  • Most ReadMost Popular StoriesMore>>

  • City of Hattiesburg employee fails to register as sex offender

    City of Hattiesburg employee fails to register as sex offender

    Thursday, July 31 2014 12:04 PM EDT2014-07-31 16:04:34 GMT
    A City of Hattiesburg employee is behind bars for failing to register as a sex offender. Public Works employee Martaze Denzel Hammond, 35, was arrested Wednesday by the Forrest County Sheriff's DepartmentMore >>
    A City of Hattiesburg employee is behind bars for failing to register as a sex offender. Public Works employee Martaze Denzel Hammond, 35, was arrested Wednesday by the Forrest County Sheriff's Department after exceeding a 90 day period in which to register as a sex offender.More >>
  • Lamar Co. man sentenced in federal court on drug charges

    Lamar Co. man sentenced in federal court on drug charges

    Thursday, July 31 2014 12:31 PM EDT2014-07-31 16:31:27 GMT
    A Lamar County man has been sentenced to nearly 8 years in federal prison on drug charges. Tommy Lucas, 48, was sentenced to 95 months by U.S. District Court Judge Keith Starrett Thursday morning. LuacsMore >>
    A Lamar County man has been sentenced to nearly 8 years in federal prison on drug charges. Tommy Lucas, 48, was sentenced to 95 months by U.S. District Court Judge Keith Starrett Thursday morningMore >>
  • Four arrested after attempted correctional facility drug crime

    Four arrested after attempted correctional facility drug crime

    Thursday, July 31 2014 4:21 PM EDT2014-07-31 20:21:06 GMT
    Four suspects were arrested Thursday during an attempt to commit a crime at the South Mississippi Correctional Institution. According to prison officials, officers responded to a fence alarm around 5 a.m.,More >>
    Four suspects were arrested Thursday during an attempt to commit a crime at the South Mississippi Correctional Institution. According to prison officials, officers responded to a fence alarm around 5 a.m., July 31, 2014, at the SMCI campus located in Leakesville, MS where officers found two packages. K9 personnel picked up a trail of the suspects which lead towards Wildcat Corner, located at the corner of High School Road and Hwy. 57 near Leakesville.More >>

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Adamas Pharmaceuticals, Inc.

EMERYVILLE, Calif., June 16, 2014 /PRNewswire/ -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that Gregory T. Went, PhD., Chief Executive Officer, will present at the JMP Securities Healthcare Conference 2014 in New York on Tuesday, June 24, 2014 at 1:00 PM Eastern Standard Time.

The presentation will be webcast live and available for replay from the Adamas website at http://ir.adamaspharma.com/events.cfm in the Investor Relations section until, July 8, 2014.

About Adamas
Adamas Pharmaceuticals, Inc. is a specialty pharmaceutical company driven to improve the lives of those affected by chronic disorders of the central nervous system. The company achieves this by modifying the pharmacokinetic profiles of approved drugs to create novel therapeutics for use alone or in fixed-dose combination products. Adamas is currently developing its lead wholly-owned product candidate, ADS-5102, for a complication of Parkinson's disease known as levodopa-induced dyskinesia, or LID, and as a potential treatment for chronic behavioral symptoms associated with traumatic brain injury, or TBI. The company's portfolio also includes a fixed-dose combination product candidate, MDX-8704, being developed with Forest Laboratories, Inc. and an approved controlled-release product, Namenda XR®, which Forest developed and is marketing in the United States under an exclusive license from Adamas. For more information, please visit www.adamaspharma.com.

Namenda XR® is a registered trademark of Merz Pharma GmbH & Co. KGaA.

©2012 PR Newswire. All Rights Reserved.